Rxo logo

Rxo share price today

(RXO)

Rxo share price is $23.46 & ₹1,996.33 as on 24 Dec 2024, 2.30 'hrs' IST

$23.46

-1.54

(-6.16%)

Market is closed - opens 8 PM, 24 Dec 2024

View live Rxo share price in Dollar and Rupees. Guide to invest in Rxo from India. Also see the sentimental analysis on Indian investors investing in Rxo. Get details on the Indian mutual funds that are investing in Rxo. Get Analyst recommendations and forecasts along with all the Rxo's financials.

Rxo share price movements

  • Today's Low: $23.44
    Today's High: $24.74

    Day's Volatility :5.24%

  • 52 Weeks Low: $18.75
    52 Weeks High: $32.82

    52 Weeks Volatility :42.87%

Rxo Returns

PeriodRxo IncIndex (Russel 2000)
3 Months
-13.43%
0.0%
6 Months
-5.44%
0.0%
1 Year
-2.78%
0.0%
3 Years
23.08%
-21.1%

Rxo Key Statistics

in dollars & INR

Previous Close
$25.0
Open
$24.79
Today's High
$24.735
Today's Low
$23.44
Market Capitalization
$4.0B
Today's Volume
$1.5M
52 Week High
$32.82
52 Week Low
$18.75
Revenue TTM
$3.9B
EBITDA
$108.0M
Earnings Per Share (EPS)
$-2.14
Profit Margin
-6.81%
Quarterly Earnings Growth YOY
-0.93%
Return On Equity TTM
-23.46%

How to invest in Rxo from India?

It is very easy for Indian residents to invest directly in Rxo from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rxo stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rxo or RXO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rxo or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rxo shares which would translate to 0.036 fractional shares of Rxo as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rxo, in just a few clicks!

Returns in Rxo for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rxo investment value today

Current value as on today

₹99,545

Returns

₹455

(-0.45%)

Returns from Rxo Stock

₹2,777 (-2.78%)

Dollar Returns

₹2,322 (+2.32%)

Indian investors sentiment towards Rxo

38%

Period: Sep 24, 2024 to Dec 23, 2024. Change in 30 Days versus previous period

Search volume for Rxo on INDmoney from India has grown in the last 30 days as on Dec 24, 2024. 38% more investors are searching Rxo in the last 30 days versus the previous period.

Global Institutional Holdings in Rxo

  • Orbis Allan Gray Ltd

    17.76%

  • MFN Partners Management, LP

    17.15%

  • BlackRock Inc

    11.10%

  • Vanguard Group Inc

    9.45%

  • Fidelity International Ltd

    3.56%

  • State Street Corp

    3.19%

Analyst Recommendation on Rxo

Hold

    35%Buy

    50%Hold

    15%Sell

Based on 20 Wall street analysts offering stock ratings for Rxo(by analysts ranked 0 to 5 stars)

Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
8
Hold
10
9
10
Sell
3
3
3

Analyst Forecast on Rxo

What analysts predicted

Upside of 16.69%

Current:

$23.46

Target:

$27.38

Insights on Rxo

  • Price Movement

    In the last 7 days, RXO stock has moved down by -11.5%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 913.0M → 1.04B (in $), with an average increase of 6.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -7.0M → -243.0M (in $), with an average decrease of 3371.4% per quarter
  • RXO vs XPO (1 yr)

    In the last 1 year, Xpo Inc. has given 48.5% return, outperforming this stock by 50.3%
  • Price to Sales

    ForRXO every $1 of sales, investors are willing to pay $0.7, whereas for Xpo Inc., the investors are paying $1.9 for every $1 of sales.

Rxo Financials in INR & Dollars

FY19Y/Y Change
Revenue
$3.1B
-
Net Income
$62.0M
-
Net Profit Margin
1.97%
-
FY20Y/Y Change
Revenue
$3.4B
↑ 6.88%
Net Income
$43.0M
↓ 30.65%
Net Profit Margin
1.28%
↓ 0.69%
FY21Y/Y Change
Revenue
$4.7B
↑ 39.68%
Net Income
$150.0M
↑ 248.84%
Net Profit Margin
3.2%
↑ 1.92%
FY22Y/Y Change
Revenue
$4.8B
↑ 2.28%
Net Income
$92.0M
↓ 38.67%
Net Profit Margin
1.92%
↓ 1.28%
FY23Y/Y Change
Revenue
$3.9B
↓ 18.12%
Net Income
$4.0M
↓ 95.65%
Net Profit Margin
0.1%
↓ 1.82%
Q2 FY23Q/Q Change
Revenue
$963.0M
↓ 4.65%
Net Income
$3.0M
↑ 7592.31%
Net Profit Margin
0.31%
↑ 0.31%
Q3 FY23Q/Q Change
Revenue
$976.0M
↑ 1.35%
Net Income
$-1000.0K
↓ 133.33%
Net Profit Margin
-0.1%
↓ 0.41%
Q4 FY23Q/Q Change
Revenue
$978.0M
↑ 0.2%
Net Income
$2.0M
↓ 300.0%
Net Profit Margin
0.2%
↑ 0.3%
Q1 FY24Q/Q Change
Revenue
$913.0M
↓ 6.65%
Net Income
$-15.0M
↓ 850.0%
Net Profit Margin
-1.64%
↓ 1.84%
Q2 FY24Q/Q Change
Revenue
$930.0M
↑ 1.86%
Net Income
$-7.0M
↓ 53.33%
Net Profit Margin
-0.75%
↑ 0.89%
Q3 FY24Q/Q Change
Revenue
$1.0B
↑ 11.83%
Net Income
$-243.0M
↑ 3371.43%
Net Profit Margin
-23.37%
↓ 22.62%
FY19Y/Y Change
Profit
$727.0M
-
FY20Y/Y Change
Profit
$789.0M
↑ 8.53%
FY21Y/Y Change
Profit
$1.0B
↑ 27.76%
FY22Y/Y Change
Profit
$1.2B
↑ 16.27%
FY23Y/Y Change
Profit
$658.0M
↓ 43.86%
Q2 FY23Q/Q Change
Profit
$240.0M
↓ 4.38%
Q3 FY23Q/Q Change
Profit
$234.0M
↓ 2.5%
Q4 FY23Q/Q Change
Profit
$235.0M
↑ 0.43%
Q1 FY24Q/Q Change
Profit
$198.0M
↓ 15.74%
Q2 FY24Q/Q Change
Profit
$213.0M
↑ 7.58%
Q3 FY24Q/Q Change
Profit
$161.0M
↓ 24.41%
FY19Y/Y Change
Operating Cash Flow
$123.0M
-
Investing Cash Flow
$-55.0M
-
Financing Cash Flow
$-47.0M
-
FY20Y/Y Change
Operating Cash Flow
$25.0M
↓ 79.67%
Investing Cash Flow
$-39.0M
↓ 29.09%
Financing Cash Flow
$32.0M
↓ 168.09%
FY21Y/Y Change
Operating Cash Flow
$155.0M
↑ 520.0%
Investing Cash Flow
$-38.0M
↓ 2.56%
Financing Cash Flow
$-158.0M
↓ 593.75%
FY22Y/Y Change
Operating Cash Flow
$310.0M
↑ 100.0%
Investing Cash Flow
$-56.0M
↑ 47.37%
Financing Cash Flow
$-183.0M
↑ 15.82%
Q2 FY23Q/Q Change
Operating Cash Flow
$24.0M
↓ 42.86%
Investing Cash Flow
$-16.0M
↑ 33.33%
Financing Cash Flow
$-5.0M
↓ 37.5%
Q3 FY23Q/Q Change
Operating Cash Flow
$4.0M
↓ 83.33%
Investing Cash Flow
$-47.0M
↑ 193.75%
Financing Cash Flow
$-4.0M
↓ 20.0%

Rxo Technicals Summary

Sell

Neutral

Buy

Rxo is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Rxo Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rxo Inc
-22.88%
-5.44%
-2.78%
23.08%
23.08%
Saia Inc
-16.58%
-0.45%
1.53%
39.57%
98.67%
Xpo Inc.
-12.32%
26.81%
47.49%
73.5%
66.61%
Knight-swift Transportation Holdings Inc.
-10.08%
9.67%
-9.97%
-13.27%
47.24%
Old Dominion Freight Line Inc.
-19.97%
3.04%
-13.38%
1.33%
187.11%
Tfi International Inc
-7.4%
-0.65%
3.83%
25.0%
289.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rxo Inc
660.67
NA
3.33
0.13
-0.23
0.01
NA
10.27
Saia Inc
33.79
33.79
2.34
13.53
0.18
0.11
NA
84.13
Xpo Inc.
43.91
43.91
1.38
3.61
0.26
0.06
NA
14.1
Knight-swift Transportation Holdings Inc.
225.87
225.87
0.99
1.06
0.01
0.01
0.01
43.61
Old Dominion Freight Line Inc.
31.55
31.55
2.71
5.44
0.3
0.19
0.01
19.53
Tfi International Inc
25.18
25.18
NA
6.19
0.17
0.07
0.01
32.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rxo Inc
Hold
$4.0B
23.08%
660.67
-6.81%
Saia Inc
Buy
$12.6B
98.67%
33.79
11.83%
Xpo Inc.
Buy
$15.7B
66.61%
43.91
4.57%
Knight-swift Transportation Holdings Inc.
Buy
$8.4B
47.24%
225.87
0.5%
Old Dominion Freight Line Inc.
Hold
$38.5B
187.11%
31.55
21.03%
Tfi International Inc
Buy
$11.7B
289.75%
25.18
5.67%

About Rxo

Organization
Rxo
Employees
6051
CEO
Mr. Drew M. Wilkerson
Industry
Transportation

Management People of Rxo

NameTitle
Mr. Drew M. Wilkerson
CEO & Director
Mr. James E. Harris
Chief Financial Officer
Mr. Jeff Firestone
Chief Legal Officer
Mr. Jason S. Kerr
Chief Accounting Officer
Mr. Yoav Amiel
Chief Information Officer
Ms. Nina Reinhardt
Chief Communications Officer
Mr. Lyndon Cron
Senior Vice President of Sales
Mr. Jared Ian Weisfeld
Chief Strategy Officer
Mr. Louis J. Amo
President of Truck Brokerage
Mr. Demetri Venetis
President of Freight Forwarding

Important FAQs about investing in Rxo from India :

What is Rxo share price today?

Rxo share price today stands at $23.46, Open: $24.79 ; Previous Close: $25.00 ; High: $24.74 ; Low: $23.44 ; 52 Week High: $32.82 ; 52 Week Low: $18.75. The stock opens at $24.79, after a previous close of $25.00. The stock reached a daily high of $24.74 and a low of $23.44, with a 52-week high of $32.82 and a 52-week low of $18.75.

Can Indians buy Rxo shares?

Yes, Indians can invest in the Rxo (RXO) from India.

With INDmoney, you can buy Rxo at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rxo at zero transaction cost.

How can I buy Rxo shares from India?

It is very easy to buy Rxo from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rxo be purchased?

Yes, you can buy fractional shares of Rxo with INDmoney app.

What are the documents required to start investing in Rxo stocks?

To start investing in Rxo, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rxo

Today’s highest price of Rxo (RXO) is $24.74.

Today’s lowest price of Rxo (RXO) is $23.44.

What is today's market capitalisation of Rxo

Today's market capitalisation of Rxo RXO is 4.0B

What is the 52 Week High and Low Range of Rxo

  • 52 Week High

    $32.82

  • 52 Week Low

    $18.75

What are the historical returns of Rxo?

  • 1 Month Returns

    -22.88%

  • 3 Months Returns

    -5.44%

  • 1 Year Returns

    -2.78%

  • 5 Years Returns

    23.08%

Who is the Chief Executive Officer (CEO) of Rxo

Mr. Drew M. Wilkerson is the current Chief Executive Officer (CEO) of Rxo.